STOCK TITAN

Innovate (VATE) Stock News

VATE NYSE

Welcome to our dedicated page for Innovate news (Ticker: VATE), a resource for investors and traders seeking the latest updates and insights on Innovate stock.

INNOVATE Corp. reports developments across a diversified portfolio organized around Infrastructure, Life Sciences and Spectrum. News commonly covers consolidated earnings, subsidiary performance, DBM Global cash dividends, steel construction activity, Spectrum network and broadcasting updates, and capital or operating developments within portfolio companies.

Life Sciences updates center on MediBeacon, an equity method investment developing fluorescent tracer agents and transdermal detection for kidney function assessment through the TGFR System, including FDA, NMPA and CE Mark regulatory milestones. INNOVATE also reports R2 system sales and commercial agreements as part of its portfolio-company operating updates.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.09%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.18%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.37%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
-
Rhea-AI Summary

INNOVATE Corp. (NYSE: VATE) announced its financial results for Q1 2023 will be released on May 2, 2023, post-market. The Company will host an earnings conference call the same day at 4:30 p.m. ET, discussing its results, operations, and strategy. Participants can access the call via the Investor Relations website or by dialing the provided numbers. A replay will be available for those unable to attend live. INNOVATE operates in Infrastructure, Life Sciences, and Spectrum sectors and employs approximately 3,800 people across its subsidiaries. For more information, visit www.INNOVATECorp.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
conferences earnings
-
Rhea-AI Summary

INNOVATE Corp. (NYSE: VATE) announced the adoption of a new Tax Benefits Preservation Plan on April 3, 2023, aimed at safeguarding its net operating loss carryforwards (NOLs) and other tax attributes following the expiration of a prior plan. As of December 31, 2022, the company had approximately $226.3 million in federal NOLs and $169.2 million in Section 163j interest limitation carryforwards. The new plan will limit ownership changes that could jeopardize these tax assets by deterring individuals or groups from acquiring over 4.9% of shares. The plan will terminate on October 1, 2023, unless extended by shareholder approval at the 2023 annual meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
none
Rhea-AI Summary

INNOVATE Corp. (NYSE: VATE) reported strong financial results for the fourth quarter and fiscal year 2022, achieving a 3.7% increase in quarterly revenue to $409.3 million and a 35.9% annual revenue growth to $1,637.3 million. Despite a net loss of $7 million for the quarter, this marked an 82.2% reduction from 2021. Key segments, including Infrastructure with $1.6 billion in revenue, contributed to these results. Adjusted EBITDA rose 27.1% in Q4, totaling $28.1 million. The company also met NYSE compliance standards for share price, ensuring continued trading.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags

FAQ

What is the current stock price of Innovate (VATE)?

The current stock price of Innovate (VATE) is $14.81 as of July 4, 2026.

What is the market cap of Innovate (VATE)?

The market cap of Innovate (VATE) is approximately 202.0M.